Tactile Systems Technology, Inc.
NASDAQ:TCMDMedical - Devices
+$0.37 today
- Market cap
- $591.84M
- Beta
- 0.83
- P/E (TTM)
- 29.1
- EPS (TTM)
- $0.90
Volume 0.22M
Average 0.30M
TCMD Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Tactile Systems Technology, Inc.NASDAQ: TCMD
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $2.78M rose 59.4% year over year, ahead of the +12.9% change in trailing-twelve-month research & development. Sequentially, it rose 9.7% from the prior quarter. Over 3 fiscal years it compounded at +6.2% a year.
Context
- Research & development amounted to 2.6% of revenue in FY2025, down 0.4 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +59.4% holds above the trailing-twelve-month pace of +12.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 8.48M USD
- Year-over-year change
- -4.0%
- 4-year CAGR
- +10.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.48M | -4.0% |
| FY2024 | 2024-12-31 | 8.83M | +12.9% |
| FY2023 | 2023-12-31 | 7.82M | +10.4% |
| FY2022 | 2022-12-31 | 7.09M | +25.3% |
| FY2021 | 2021-12-31 | 5.66M | — |
Research & Development vs competitors
How TCMD compares with its peers on the latest reported figures
- TCMD's LTM Mar 2026 research & development of $9.52M is the highest of the 2 companies compared; the peer median is $1.29M.
- Its year-over-year change of +12.9% is the lowest of 2, against a peer median of +48.0%.
- Research & development amounts to 2.8% of revenue for TCMD, versus a peer median of 1.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $9.52M | +12.9% | +6.2% | 2.8% | |
| LTM Mar 2026 | $1.29M | +48.0% | -9.8% | 1.8% | |
| Peer median (excluding TCMD) | $1.29M | +48.0% | -9.8% | 1.8% | |
Competitors are the stored peer set for TCMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 208.06M | 246.79M | 274.42M | 292.98M | 329.52M |
| Cost of Revenue | 59.84M | 70.81M | 79.29M | 76.3M | 81.82M |
| Gross Profit | 148.21M | 175.98M | 195.13M | 216.69M | 247.7M |
| Gross Margin | 71.2% | 71.3% | 71.1% | 74.0% | 75.2% |
| Research & Development | 5.66M | 7.09M | 7.82M | 8.83M | 8.48M |
| Selling, General & Admin | 143.58M | 167.21M | 169.19M | 183.14M | 209.94M |
| Operating Expenses | 149.98M | 188.73M | 177.09M | 194.51M | 218.42M |
| Depreciation & Amortization | 3.68M | 14.43M | 6.5M | 6.8M | 6.64M |
| EBITDA | 1.39M | 1.75M | 26.42M | 32.37M | 39.02M |
| EBITDA Margin | 0.7% | 0.7% | 9.6% | 11.0% | 11.8% |
| Operating Income | (1.76M) | (12.76M) | 18.04M | 22.18M | 29.28M |
| Operating Margin | -0.8% | -5.2% | 6.6% | 7.6% | 8.9% |
| Interest Income | 0 | 60K | 1.87M | 3.38M | 3.1M |
| Interest Expense | 0 | 2.79M | 4.15M | 2.09M | 1.04M |
| Other Income / Expenses | (531K) | (2.72M) | (2.27M) | 1.31M | 2.06M |
| Income Before Tax | (2.29M) | (15.47M) | 15.77M | 23.49M | 31.34M |
| Pre-Tax Margin | -1.1% | -6.3% | 5.7% | 8.0% | 9.5% |
| Income Tax Expense | 9.52M | 2.39M | (12.75M) | 6.53M | 12.25M |
| Net Income | (11.81M) | (17.87M) | 28.52M | 16.96M | 19.09M |
| Net Margin | -5.7% | -7.2% | 10.4% | 5.8% | 5.8% |
| EPS (Basic) | (0.60) | (0.89) | 1.24 | 0.71 | 0.83 |
| EPS (Diluted) | (0.60) | (0.89) | 1.23 | 0.70 | 0.82 |
| Weighted Avg Shares | 19.72M | 20.07M | 22.93M | 23.88M | 22.87M |
| Weighted Avg Shares (Diluted) | 19.72M | 20.07M | 23.18M | 24.14M | 23.3M |
Tactile Systems Technology, Inc.
NASDAQ:TCMD
Intrinsic Alpha fair value
Locked
Current Price
$26.42
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.